{
  "retracted": false,
  "timestamp": 1519257600000,
  "updates": [
    {
      "timestamp": 1574806445091,
      "identifier": {
        "doi": "10.3310/hta21020-c201802"
      },
      "type": "corrigendum"
    }
  ],
  "identifier": {
    "doi": "10.3310/hta21020"
  },
  "publisher": "National Institute for Health Research",
  "title": "Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation"
}
